Flexion Therapeutics Inc. has named Mark Levine as its first general counsel and senior vice president. Levine has more than 20 years of corporate legal experience, having previously served as GC at Minerva Neurosciences Inc., assistant GC at athenahealth Inc., and associate GC at Clinical Data Inc., according to his LinkedIn profile.
“Mark’s extensive experience in biotechnology and life-science companies will be invaluable” as the company prepares to market a new drug, according to a June 28 statement from Michael Clayman, M.D., president and CEO of Flexion, which is located in Burlington, Massachusetts.
